We are live on
!
Find out more
Aviva Portfolio holdings
AUM
$59.6B
1-Year Est. Return
28.44%
This Fund
S&P 500
This Quarter
Est. Return
+1.47%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$14.6B
AUM Growth
+$1.71B
(+13%)
Cap. Flow
+$1.58B
Cap. Flow
% of AUM
10.84%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
856
New
17
Increased
646
Reduced
63
Closed
34
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$52.7M |
| 2 |
ExxonMobil
XOM
|
+$47.8M |
| 3 |
Cisco
CSCO
|
+$37.5M |
| 4 |
Ford
F
|
+$36.3M |
| 5 |
Johnson & Johnson
JNJ
|
+$35.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UGI
UGI
|
+$35.5M |
| 2 |
QGENF
QIAGEN NV
QGENF
|
+$34.9M |
| 3 |
AGN
Allergan Inc
AGN
|
+$26.5M |
| 4 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$25.5M |
| 5 |
AMT.PRA
American Tower Corporation
AMT.PRA
|
+$20.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.27% |
| 2 | Technology | 13.75% |
| 3 | Healthcare | 13.38% |
| 4 | Industrials | 9.06% |
| 5 | Consumer Discretionary | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Apple
AAPL
$4.75T
| $503M | 3.45% |
16,176,788
+1,744,372
| +12% | +$52.7M |
|
|
2
ExxonMobil
XOM
$647B
| $215M | 1.47% |
2,528,766
+538,768
| +27% | +$47.8M |
|
3
Microsoft
MSFT
$2.85T
| $213M | 1.46% |
5,244,227
+626,291
| +14% | +$27.3M |
|
4
Alphabet (Google) Class C
GOOG
$3.92T
| $202M | 1.38% |
7,342,865
+1,244,147
| +20% | +$33.3M |
|
|
5
Johnson & Johnson
JNJ
$630B
| $184M | 1.26% |
1,831,448
+351,874
| +24% | +$35.8M |
|
6
GE Aerospace
GE
$364B
| $174M | 1.19% |
1,466,324
+210,637
| +17% | +$25.1M |
|
7
JPMorgan Chase
JPM
$928B
| $174M | 1.19% |
2,871,532
+287,039
| +11% | +$17M |
|
8
Wells Fargo
WFC
$260B
| $174M | 1.19% |
3,195,699
+478,332
| +18% | +$25.9M |
|
9
Pfizer
PFE
$140B
| $171M | 1.17% |
5,179,928
-368,345
| -7% | -$11.7M |
|
10
UBS Group
UBS
$169B
| $152M | 1.04% |
8,071,906
+179,434
| +2% | +$3.12M |
|
11
Procter & Gamble
PG
$339B
| $139M | 0.96% |
1,701,100
+286,106
| +20% | +$24.6M |
|
12
AT&T
T
$160B
| $133M | 0.91% |
5,397,674
+407,113
| +8% | +$10.3M |
|
13
Chevron
CVX
$387B
| $122M | 0.84% |
1,166,135
+256,395
| +28% | +$27.4M |
|
14
Home Depot
HD
$324B
| $122M | 0.84% |
1,077,377
+64,103
| +6% | +$7.07M |
|
15
Amgen
AMGN
$202B
| $122M | 0.84% |
763,616
+65,720
| +9% | +$10.4M |
|
16
Verizon
VZ
$186B
| $122M | 0.83% |
2,503,448
+216,074
| +9% | +$10.4M |
|
17
Qualcomm
QCOM
$179B
| $118M | 0.81% |
1,704,734
+79,138
| +5% | +$5.58M |
|
18
IBM
IBM
$196B
| $113M | 0.78% |
739,163
+98,455
| +15% | +$14.9M |
|
19
Boeing
BA
$165B
| $113M | 0.78% |
755,543
+4,908
| +0.7% | +$715K |
|
20
Gilead Sciences
GILD
$162B
| $112M | 0.77% |
1,144,467
+351,918
| +44% | +$35.7M |
|
21
Bank of America
BAC
$430B
| $110M | 0.75% |
7,135,073
+1,278,438
| +22% | +$20.5M |
|
22
Merck
MRK
$324B
| $110M | 0.75% |
1,998,074
+314,788
| +19% | +$17.8M |
|
23
Coca-Cola
KO
$349B
| $108M | 0.74% |
2,670,630
+319,286
| +14% | +$13.4M |
|
24
Citigroup
C
$222B
| $107M | 0.73% |
2,073,198
+303,569
| +17% | +$15.5M |
|
25
Simon Property Group
SPG
$73.3B
| $107M | 0.73% |
545,864
+32,453
| +6% | +$6.29M |
|
Similar funds
QCM
NAMI
Aviva's Q1 2015 Portfolio in Review
As of Q1 2015, Aviva held 856 positions worth $14.6B, up 13% from $12.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Aviva deployed $1.58B of net new capital in Q1 2015, opening 17 new positions and adding to 646 existing holdings. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 14,000 shares worth $14.4M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was UGI, an estimated $35.5M trimmed.
- Aviva's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 14,000 shares worth $14.4M.
- Aviva added most to Apple in Q1 2015, an estimated $52.7M increase.
- Aviva's biggest Q1 2015 reduction was UGI, cutting an estimated $35.5M.
- Aviva fully exited Allergan Inc in Q1 2015, selling an estimated $26.5M.
- Aviva's ten largest holdings make up 15% of its $14.6B portfolio in Q1 2015.
- Aviva opened 17 new positions and closed 34 in Q1 2015.
- Aviva's portfolio value rose 13% quarter-over-quarter to $14.6B.
Based on Aviva's 13F filing for Q1 2015, filed 14 May 2015.